These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 25500583)

  • 1. Decreased serum level of miR-146a as sign of chronic inflammation in type 2 diabetic patients.
    Baldeón R L; Weigelt K; de Wit H; Ozcan B; van Oudenaren A; Sempértegui F; Sijbrands E; Grosse L; Freire W; Drexhage HA; Leenen PJ
    PLoS One; 2014; 9(12):e115209. PubMed ID: 25500583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Circulating MicroRNAs and Myokines and Interactions with Serum Osteopontin in Type 2 Diabetic Patients with Moderate and Poor Glycemic Control: A Biochemical and Molecular Study.
    Al-Rawaf HA; Alghadir AH; Gabr SA
    Biomed Res Int; 2021; 2021():7453000. PubMed ID: 34917685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating miR-146a, miR-34a and miR-375 in type 2 diabetes patients, pre-diabetic and normal-glycaemic individuals in relation to β-cell function, insulin resistance and metabolic parameters.
    García-Jacobo RE; Uresti-Rivera EE; Portales-Pérez DP; González-Amaro R; Lara-Ramírez EE; Enciso-Moreno JA; García-Hernández MH
    Clin Exp Pharmacol Physiol; 2019 Dec; 46(12):1092-1100. PubMed ID: 31355469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study on inflammation-related genes and microRNAs, with special emphasis on the vascular repair factor HGF and miR-574-3p, in monocytes and serum of patients with T2D.
    Baldeón Rojas L; Weigelt K; de Wit H; Ozcan B; van Oudenaren A; Sempértegui F; Sijbrands E; Grosse L; van Zonneveld AJ; Drexhage HA; Leenen PJ
    Diabetol Metab Syndr; 2016; 8():6. PubMed ID: 26779287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The rs2910164 variant is associated with reduced miR-146a expression but not cytokine levels in patients with type 2 diabetes.
    Alipoor B; Ghaedi H; Meshkani R; Omrani MD; Sharifi Z; Golmohammadi T
    J Endocrinol Invest; 2018 May; 41(5):557-566. PubMed ID: 29058209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered levels of circulating cytokines and microRNAs in lean and obese individuals with prediabetes and type 2 diabetes.
    Nunez Lopez YO; Garufi G; Seyhan AA
    Mol Biosyst; 2016 Dec; 13(1):106-121. PubMed ID: 27869909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum circulating microRNA profiling for identification of potential type 2 diabetes and obesity biomarkers.
    Pescador N; Pérez-Barba M; Ibarra JM; Corbatón A; Martínez-Larrad MT; Serrano-Ríos M
    PLoS One; 2013; 8(10):e77251. PubMed ID: 24204780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired miR-146a expression links subclinical inflammation and insulin resistance in Type 2 diabetes.
    Balasubramanyam M; Aravind S; Gokulakrishnan K; Prabu P; Sathishkumar C; Ranjani H; Mohan V
    Mol Cell Biochem; 2011 May; 351(1-2):197-205. PubMed ID: 21249428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum miR-23a, a potential biomarker for diagnosis of pre-diabetes and type 2 diabetes.
    Yang Z; Chen H; Si H; Li X; Ding X; Sheng Q; Chen P; Zhang H
    Acta Diabetol; 2014 Oct; 51(5):823-31. PubMed ID: 24981880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased serum microRNA-21 level is associated with obesity in healthy and type 2 diabetic subjects.
    Ghorbani S; Mahdavi R; Alipoor B; Panahi G; Nasli Esfahani E; Razi F; Taghikhani M; Meshkani R
    Arch Physiol Biochem; 2018 Oct; 124(4):300-305. PubMed ID: 29113498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Serum microRNAs in Patients with Diabetic Kidney Disease: A Nested Case-Controlled Study and Bioinformatics Analysis.
    Regmi A; Liu G; Zhong X; Hu S; Ma R; Gou L; Zafar MI; Chen L
    Med Sci Monit; 2019 Mar; 25():1699-1708. PubMed ID: 30835718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of miR-31 in Diabetic Nephropathy and its Relationship with Inflammation.
    Rovira-Llopis S; Escribano-Lopez I; Diaz-Morales N; Iannantuoni F; Lopez-Domenech S; Andújar I; Jover A; Pantoja J; Pallardo LM; Bañuls C; Victor VM
    Cell Physiol Biochem; 2018; 50(3):1005-1014. PubMed ID: 30355913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating miR-146a/b correlates with inflammatory cytokines in COPD and could predict the risk of acute exacerbation COPD.
    Chen BB; Li ZH; Gao S
    Medicine (Baltimore); 2018 Feb; 97(7):e9820. PubMed ID: 29443743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood-based analysis of 84 microRNAs identifies molecules deregulated in individuals with type-2 diabetes, risk factors for the disease or metabolic syndrome.
    Avgeris M; Kokkinopoulou I; Maratou E; Mitrou P; Boutati E; Scorilas A; Fragoulis EG; Christodoulou MI
    Diabetes Res Clin Pract; 2020 Jun; 164():108187. PubMed ID: 32360711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating microRNA-122, microRNA-126-3p and microRNA-146a are associated with inflammation in patients with pre-diabetes and type 2 diabetes mellitus: A case control study.
    Zeinali F; Aghaei Zarch SM; Jahan-Mihan A; Kalantar SM; Vahidi Mehrjardi MY; Fallahzadeh H; Hosseinzadeh M; Rahmanian M; Mozaffari-Khosravi H
    PLoS One; 2021; 16(6):e0251697. PubMed ID: 34077450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating Mir-140 and leptin improve the accuracy of the differential diagnosis between psoriatic arthritis and rheumatoid arthritis: a case-control study.
    Cheleschi S; Tenti S; Bedogni G; Fioravanti A
    Transl Res; 2022 Jan; 239():18-34. PubMed ID: 34380068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of microRNA-146a in diabetic peripheral neuropathy through the regulation of inflammation.
    Feng Y; Chen L; Luo Q; Wu M; Chen Y; Shi X
    Drug Des Devel Ther; 2018; 12():171-177. PubMed ID: 29398906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impairment of Wound Healing in Patients With Type 2 Diabetes Mellitus Influences Circulating MicroRNA Patterns via Inflammatory Cytokines.
    Dangwal S; Stratmann B; Bang C; Lorenzen JM; Kumarswamy R; Fiedler J; Falk CS; Scholz CJ; Thum T; Tschoepe D
    Arterioscler Thromb Vasc Biol; 2015 Jun; 35(6):1480-8. PubMed ID: 25814674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-146a suppresses the expression of vascular endothelial growth factor and inflammatory responses in diabetic retinopathy.
    Sun S; Wang F; Sun Y; Bai L
    Growth Factors; 2022 Aug; 40(3-4):89-97. PubMed ID: 35605149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulated miR-155 expression in peripheral blood mononuclear cells from patients with type 2 diabetes.
    Corral-Fernández NE; Salgado-Bustamante M; Martínez-Leija ME; Cortez-Espinosa N; García-Hernández MH; Reynaga-Hernández E; Quezada-Calvillo R; Portales-Pérez DP
    Exp Clin Endocrinol Diabetes; 2013 Jun; 121(6):347-53. PubMed ID: 23616185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.